Differential Impact of Valproic Acid on

CDH1 CDH2 KCC2 NKCC1 SLC5A8 T98G cell U87 MG cell adult glioblastoma valproic acid

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
25 Jun 2024
Historique:
received: 16 03 2024
revised: 13 06 2024
accepted: 22 06 2024
medline: 27 7 2024
pubmed: 27 7 2024
entrez: 27 7 2024
Statut: epublish

Résumé

Valproic acid (VPA) has anticancer, anti-inflammatory, and epigenetic effects. The study aimed to determine the expression of carcinogenesis-related

Identifiants

pubmed: 39061990
pii: biomedicines12071416
doi: 10.3390/biomedicines12071416
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Lietuvos Mokslo Taryba
ID : P-MIP-20-36.
Organisme : Lietuvos Mokslo Taryba
ID : Research Council of Lithuania, P-MIP-20-36.
Organisme : Lietuvos Mokslų Taryba
ID : Research Council of Lithuania, grant number P-MIP-20-36.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Auteurs

Milda Juknevičienė (M)

Department of Histology and Embryology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.

Ingrida Balnytė (I)

Department of Histology and Embryology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.

Angelija Valančiūtė (A)

Department of Histology and Embryology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.

Marta Marija Alonso (MM)

Department of Pediatrics, Clínica Universidad de Navarra, University of Navarra, 31008 Pamplona, Spain.

Aidanas Preikšaitis (A)

Centre of Neurosurgery, Clinic of Neurology and Neurosurgery, Faculty of Medicine, Vilnius University, 03101 Vilnius, Lithuania.

Kęstutis Sužiedėlis (K)

Laboratory of Molecular Oncology, National Cancer Institute, 08660 Vilnius, Lithuania.

Donatas Stakišaitis (D)

Department of Histology and Embryology, Medical Academy, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
Laboratory of Molecular Oncology, National Cancer Institute, 08660 Vilnius, Lithuania.

Classifications MeSH